Asim Shabbir Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Asim Shabbir's research program focuses on gastrointestinal diseases, surgical outcomes, and metabolic health. He has published work investigating single-cell atlases of lineage states in gastric cancer, the role of hedgehog signaling in mediating PD-L1 expression in gastric cancer organoids, and risk prediction models for mortality after esophagectomy for cancer. His work also extends to metabolic health, with publications on cardiovascular-liver-metabolic health recommendations for managing metabolic dysfunction-associated steatotic liver disease and the regulation of adipogenic differentiation by interferon regulatory factor 3.
Shabbir's contributions also include studies on bariatric surgery, with publications on patient selection for one anastomosis/mini gastric bypass and consensus statements on sleeve gastrectomy. He has also examined outcomes after minimally invasive versus hybrid and open esophagectomy. With a h-index of 45 and over 7,700 citations across 382 publications, his work is recognized as highly impactful and highly cited.
Metrics
- h-index: 44
- Publications: 378
- Citations: 7,736
Selected Publications
-
Ceramide-induced FGF13 impairs systemic metabolic health (2025)
-
International expert consensus on the current status and future prospects of artificial intelligence in metabolic and bariatric surgery (2025)
-
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach (2024)
-
Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease (2024)
-
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden (2024)
-
Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes (2024)
-
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases (2024)
-
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals (2024)
-
Metabolic and Bariatric Surgeon Criteria—An International Experts’ Consensus (2024)
-
Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus (2024)
-
Sex differences in optimal medical therapy following invasive angiography for coronary artery disease (2024)
-
Technical Variations and Considerations around OAGB in IFSO-APC and IFSO-MENAC Chapters, an Expert Survey (2024)
-
Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation (2024)
-
The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy (2024)
-
The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery—An International Expert Survey (2024)
Collaboration Network
Top Collaborators
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
- Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer
- Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
- Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation
Showing 5 of 21 shared publications
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
- Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases
- Gastro-esophageal reflux disease (GERD) after peroral endoscopic myotomy (POEM)
- Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus
Showing 5 of 11 shared publications
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
- Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
- Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
- Outcomes of a phase II study of intraperitoneal paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases.
Showing 5 of 10 shared publications
- Patient Selection in One Anastomosis/Mini Gastric Bypass—an Expert Modified Delphi Consensus
- Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus
- Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
- Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
- Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus
Showing 5 of 10 shared publications
- Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
- The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
- Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation
- The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome
- Socio-Demographic, Behavioral and Psychological Factors Associated with High BMI among Adults in a Southeast Asian Multi-Ethnic Society: A Structural Equation Model
Showing 5 of 10 shared publications
- Patient Selection in One Anastomosis/Mini Gastric Bypass—an Expert Modified Delphi Consensus
- The first modified Delphi consensus statement on sleeve gastrectomy
- Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus
- Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
- Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus
Showing 5 of 9 shared publications
- Patient Selection in One Anastomosis/Mini Gastric Bypass—an Expert Modified Delphi Consensus
- Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus
- Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
- Bariatric Evaluation Through AI: a Survey of Expert Opinions Versus ChatGPT-4 (BETA-SEOV)
- Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
Showing 5 of 9 shared publications
- Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
- The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
- The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome
- Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease
- Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease
Showing 5 of 8 shared publications
- The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
- Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation
- The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome
- Socio-Demographic, Behavioral and Psychological Factors Associated with High BMI among Adults in a Southeast Asian Multi-Ethnic Society: A Structural Equation Model
- Comparison of mechanistic pathways of bariatric surgery in patients with diabetes mellitus: A <scp>B</scp>ayesian network meta‐analysis
Showing 5 of 8 shared publications
- The first modified Delphi consensus statement on sleeve gastrectomy
- Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus
- Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
- Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus
- The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery—An International Expert Survey
Showing 5 of 7 shared publications
- Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
- Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases
- Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes
- Outcomes of a phase II study of intraperitoneal paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases.
- Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
Showing 5 of 7 shared publications
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
- Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
- Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes
- Outcomes of a phase II study of intraperitoneal paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases.
Showing 5 of 7 shared publications
- Patient Selection in One Anastomosis/Mini Gastric Bypass—an Expert Modified Delphi Consensus
- Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus
- Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
- Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus
- Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus
Showing 5 of 7 shared publications
- Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
- Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation
- Essential elements of weight loss apps for a multi-ethnic population with high BMI: a qualitative study with practical recommendations
- Socio-Demographic, Behavioral and Psychological Factors Associated with High BMI among Adults in a Southeast Asian Multi-Ethnic Society: A Structural Equation Model
- Anthropometric and cardiometabolic effects of polyphenols in people with overweight and obesity: an umbrella review
Showing 5 of 7 shared publications
- Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus
- Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus
- Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
- Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus
- The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery—An International Expert Survey
Showing 5 of 7 shared publications
Similar Researchers
Based on overlapping research topics